Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
This guide covers every concentration you will encounter
(2000) 279:G893902
University of Pennsylvania
July 24 Product: BioMarins Brineura Indication: Batten disease BioMarin secured an expanded approval Wednesday for Brineura, its treatment for the genetic condition called neuronal ceroid lipofuscinosis type 2 (CLN2) disease
None are FDA-approved as of May 2026
US$ 23.90
US$ 29.71
US$ 25.29
US$ 21.16
US$ 21.37
US$ 26.45
US$ 23.68
US$ 29.42
US$ 24.05
US$ 28.10
US$ 27.24
US$ 26.24
US$ 24.84
